View Clinical Trial (Medical Research Study)
Oral Glutathione and Health Outcomes Among Persons With Post-Polio Syndrome
| City: |
|
Ann Arbor |
| State: |
|
Michigan |
| Zip Code: |
|
48108 |
| Conditions: |
|
Post-polio Syndrome - Physical Activity - Depression - Pain - Sleep Disorders |
| Purpose: |
|
In this study, people who have symptoms of post polio will take oral glutathione supplements
for three months. Their levels of fatigue, physical function, sleep disturbance, impairment
and emotional distress will be measured with both subjective and objective measures.
|
| Study Summary: |
|
Subjects will take a glutathione supplement by mouth for three months after an initial
medical visit, blood draw and physical exam. There are four timepoints during the three
months when subjects will fill out surveys and record food intake and sleep times in diaries
for seven days. They will also wear a small device for seven days, a Sensewear monitor that
records physical activity, body temperature and other measures.
After the fourth timepoint they will return to the medical center for another physical exam
and blood draw. Physicians trained in physical medicine and rehabilitation will be
monitoring the study.
|
| Criteria: |
|
Inclusion Criteria:
- Ability to walk 100 feet with usual assistive devices (ex. cane or walker)
- Having a function score of 18-32 when tested with the IPPS (Index of Post- Polio
Sequelae). This will include people with post-polio symptoms in a very specific
range of severity.
Exclusion Criteria:
- Having another serious medical condition (cancer, multiple sclerosis, etc.)or
inflammatory disease (ie., lupus)
- Currently taking glutathione or other antioxidants
|
| NCT ID: |
|
NCT01402570 |
| Primary Contact: |
|
Connie Pines
Phone: 734 764-1454
Email: canewman@umich.edu
|
| Backup Contact: |
|
Kathleen Donnelly
Phone: kldonnel@umich.edu
|
| Location Contact: |
|
Ann Arbor, Michigan 48108
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 18, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|